July 7, 2020
PA-18-358,NINDS Exploratory Neuroscience Research Grant (R21- Clinical Trial Optional)
National Institute of Mental Health (NIMH)
National Institute of Neurological Disorders and Stroke (NINDS)
The purpose of this Notice is to inform potential applicants of NIMH's participation, effective immediately, in PA-18-358, " NINDS Exploratory Neuroscience Research Grant (R21- Clinical Trial Optional)" for the next receipt date of October 16, 2020.
The following sections of PA-18-358 have been updated to reflect the participation of NIMH in this Notice:
Part 1. Overview Information
Components of Participating Organizations
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute of Mental Health (NIMH)
Section I Funding Opportunity Description
Areas of scientific interest for the NIMH reflect the Neuroscience areas of priority as detailed in the NIMH Strategic Plan and found within the following divisions and offices.
The Division of Neuroscience and Basic Behavioral Science (DNBBS) supports research programs in basic neuroscience, genetics, resource and technology development, and drug discovery. Examples of priorities include but are not limited to these topics:
The Division of Translational Research (DTR) supports research that translates knowledge from basic science to discover the etiology, pathophysiology, and trajectory of mental disorders and develops effective interventions for children and adults. Examples of priorities include but are not limited to these topics:
The Division of AIDS Research (DAR) supports research on basic and clinical neuroscience of HIV infection. Examples of priorities include but are not limited to these topics:
Office of Technology Development and Coordination (OTDC): Supports basic and applied research related to the development of scientific tools, technologies, and approaches related to brain and behavioral research.
Any Clinical Trial research submitted to NIMH under this R21 mechanism must follow the guidance noted by NIMH in NOT-MH-19-006. That is, NIMH supports hypothesis-driven mechanistic clinical trial studies in basic and/or translational discovery research in health human subjects and in the pathobiology, pathophysiology and psychopathology of mental disorders and in HIV infection of the central nervous system (CNS). The goal is to address basic questions and to interrogate concept in biology, behavior, and pathophysiology that will provide insight in to understanding mental health and mental disorders. https://www.nimh.nih.gov/funding/opportunities-announcements/clinical-trials-foas/index.shtml.
Susan Koester, Ph.D.
National Institute of Mental Health (NIMH)
Telephone:301-443-3563
Email: koesters@mail.nih.gov